well what has management to say about that - time for an ANN IMO as this is quite sensitive to company. Lets now see what management say about other revenue streams to spread the risk - IMO no management performance bonuses should be paid due to this quite negative bit of news. Now management need to get their act into gear and get moving on projects - oh that's right what projects - from what I can determine none no where near commercialisation.
So if the news about FDA was in November why no ANN from management?????
us fda is investigating the safety of trt, page-2
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 142200 | 5.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.1¢ | 17617 | 1 |
View Market Depth
| Last trade - 16.12pm 07/11/2024 (20 minute delay) ? |
| ACR (ASX) Chart |
Day chart unavailable